Snac WristNCT07335783
Lunocapitate Fusion in Snac Wrist
A study testing Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist) and Lunocapitate fusion in snac wrist in people with Snac Wrist, run by Assiut University.
Trial summary
Scaphoid fractures are common, accounting for approximately 60-70% of all carpal bone fractures. StatPearls. Scaphoid Wrist Fracture. (2024). (A significant challenge is the high rate of missed or delayed diagnosis, which occurs in up to 30% of cases initially, often due to subtle radiographic findings). Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Snac Wrist
- What is being tested?
- Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist) and Lunocapitate fusion in snac wrist
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2026to 10 Mar 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- 1- Age 18-60 years 2- symptomatic SNAC wrist failed conservative management.
Who cannot join
- 1- total wrist Arthritis 2-systemic arthropathy 3-Infected wrist
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Results of Lunocapitate Fusion in Mangement of Scaphoid Non Union Advanced Collapse (SNAC Wrist)
Scaphoid fractures are common, accounting for approximately 60-70% of all carpal bone fractures. StatPearls. Scaphoid Wrist Fracture. (2024). (A significant challenge is the high rate of missed or delayed diagnosis, which occurs in up to 30% of cases initially, often due to subtle radiographic findings). [Orthobullets - Acute Scaphoid Fractures] This is critical because 10-20% of acute scaphoid fractures are prone to nonunion even with appropriate treatment,[ResearhGate - Scaphoid Non-Union]. a risk that rises dramatically to over 80-90% if the fracture is completely untreated or missed.ResearchGate Nonunion can lead to scaphoid nonunion advanced collapse (SNAC) is a progressive and debilitating wrist disorder that arises from an untreated scaphoid fracture, leading to characteristic patterns of osteoarthritis. Surgical intervention is often required to alleviate pain and improve function.National Library Of Medicine Treatment strategies vary based on fracture timing and union status. For acute, nondisplaced fractures, non-surgical management with cast immobilization for 8-12 weeks is the standard initial approach, For displaced acute fractures or cases of established nonunion, surgical intervention is mandatory. Options include open reduction and internal fixation (ORIF) with a compression screw, often with bone grafting. In advanced stages where arthritis has developed (SNAC wrist), salvage procedures like proximal row carpectomy or limited carpal fusions are required. [Orthobullets - Scaphoid Fracture Among the available salvage procedures, lunocapitate (LC) fusion with scaphoid excision presents a compelling surgical option. This technique aims to reduce pain by eliminating the arthritic joint surfaces and stabilizing the midcarpal joint. The theoretical advantages of LC fusion include a simplified biomechanicalconstruct with fewer fusion surfaces, which may potentially lead to a higher rate of arthrodesis, and preservation of a functional range of motion. However, comprehensive prospective studies detailing the outcomes, union rates, and complication profile of this specific procedure are still relatively scarce in the literature. ResearchGate - Lunate-capitate arthrodesis (2024)]. This study is designed to prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist. The rationale is to provide robust clinical data that can solidify the role of LC fusion in the management algorithm of this condition.
Lunocapitate (LC) fusion has emerged as a promising salvage technique. By reducing the number of fusion sites compared to other procedures, it aims to achieve a higher union rate, reduce operative time, and better preserve wrist motion. However,comprehensive prospective data on its outcomes are still needed. This study will prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist.
- Conditions
- Snac Wrist
- Being tested
- Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist), Lunocapitate fusion in snac wrist
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist)Procedure or surgery
Lunocapitate fusion in snac wrist
Lunocapitate fusion in snac wristProcedure or surgery
Lunocapitate (LC) fusion has emerged as a promising salvage technique. By reducing the number of fusion sites compared to other procedures, it aims to achieve a higher union rate, reduce operative time, and better preserve wrist motion. However,comprehensive prospective data on its outcomes are still needed. This study will prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist.
| Study group | Role | What they receive |
|---|---|---|
| Lunocapitate fusion | Experimental | Not described Receives: Procedure: Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist); Procedure: Lunocapitate fusion in snac wrist |
What is being measured
The primary outcome is the main question the study is designed to answer.
DASH SCORE
Measured: 12 month
Functional outcome measured by the DASH score at 12 months post-operation
Measured: 12 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2026
- Study start1 Jan 2026 (estimated)
- Primary completion30 Dec 2028 (estimated)
- Study completion10 Mar 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Snac WristStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 35 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Hany Ahmed Ali, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07335783
- Sponsor's protocol ID
- Snac wrist lunocapitate fusion
- Status last verified
- Dec 2025
- First submitted
- 31 Dec 2025
- Last updated
- 13 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 13 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Results of Lunocapitate Fusion in Mangement of Scaphoid Non Union Advanced Collapse (SNAC Wrist)
- ClinicalTrials.gov ID
- NCT07335783
- Acronym / sponsor ID
- Snac wrist lunocapitate fusion
- Conditions
- Snac Wrist
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Jan 2026 (estimated)
- Primary completion
- 30 Dec 2028 (estimated)
- Study completion
- 10 Mar 2029 (estimated)
- First posted
- 13 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Scaphoid fractures are common, accounting for approximately 60-70% of all carpal bone fractures. StatPearls. Scaphoid Wrist Fracture. (2024). (A significant challenge is the high rate of missed or delayed diagnosis, which occurs in up to 30% of cases initially, often due to subtle radiographic findings). [Orthobullets - Acute Scaphoid Fractures] This is critical because 10-20% of acute scaphoid fractures are prone to nonunion even with appropriate treatment,[ResearhGate - Scaphoid Non-Union]. a risk that rises dramatically to over 80-90% if the fracture is completely untreated or missed.ResearchGate Nonunion can lead to scaphoid nonunion advanced collapse (SNAC) is a progressive and debilitating wrist disorder that arises from an untreated scaphoid fracture, leading to characteristic patterns of osteoarthritis. Surgical intervention is often required to alleviate pain and improve function.National Library Of Medicine Treatment strategies vary based on fracture timing and union status. For acute, nondisplaced fractures, non-surgical management with cast immobilization for 8-12 weeks is the standard initial approach, For displaced acute fractures or cases of established nonunion, surgical intervention is mandatory. Options include open reduction and internal fixation (ORIF) with a compression screw, often with bone grafting. In advanced stages where arthritis has developed (SNAC wrist), salvage procedures like proximal row carpectomy or limited carpal fusions are required. [Orthobullets - Scaphoid Fracture Among the available salvage procedures, lunocapitate (LC) fusion with scaphoid excision presents a compelling surgical option. This technique aims to reduce pain by eliminating the arthritic joint surfaces and stabilizing the midcarpal joint. The theoretical advantages of LC fusion include a simplified biomechanicalconstruct with fewer fusion surfaces, which may potentially lead to a higher rate of arthrodesis, and preservation of a functional range of motion. However, comprehensive prospective studies detailing the outcomes, union rates, and complication profile of this specific procedure are still relatively scarce in the literature. ResearchGate - Lunate-capitate arthrodesis (2024)]. This study is designed to prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist. The rationale is to provide robust clinical data that can solidify the role of LC fusion in the management algorithm of this condition.
Lunocapitate (LC) fusion has emerged as a promising salvage technique. By reducing the number of fusion sites compared to other procedures, it aims to achieve a higher union rate, reduce operative time, and better preserve wrist motion. However,comprehensive prospective data on its outcomes are still needed. This study will prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Lunocapitate fusion | Experimental | Procedure: Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist), Procedure: Lunocapitate fusion in snac wrist |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- 1- Age 18-60 years 2- symptomatic SNAC wrist failed conservative management.
Key exclusion criteria (1 listed)
- 1- total wrist Arthritis 2-systemic arthropathy 3-Infected wrist
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist)Lunocapitate fusion in snac wrist | Procedure or surgery | Lunocapitate fusion |
| Lunocapitate fusion in snac wristLunocapitate (LC) fusion has emerged as a promising salvage technique. By reducing the number of fusion sites compared to other procedures, it aims to achieve a higher union rate, reduce operative time, and better preserve wrist motion. However,comprehensive prospective data on its outcomes are still needed. This study will prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist. | Procedure or surgery | Lunocapitate fusion |
Primary outcome
DASH SCORE
Time frame: 12 month
Functional outcome measured by the DASH score at 12 months post-operation
Time frame: 12 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jan 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist) and Lunocapitate fusion in snac wrist in people with Snac Wrist, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ahmed Hany Ahmed (00201151469790, ahani3964@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
DASH SCORE (time frame: 12 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2026; AzTrials last refreshed its copy on 6 Nov 2026.